Asterias Biotherapeutics Inc (AST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -4,815 | -2,150 | -816 | 0 |
| Depreciation Amortization | 95 | 37 | 11 | 0 |
| Accounts payable and accrued liabilities | 354 | 209 | N/A | N/A |
| Other Working Capital | 6,000 | 2,784 | 857 | 0 |
| Other Operating Activity | 85 | -187 | 3 | 0 |
| Operating Cash Flow | $1,719 | $693 | $54 | $0 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,573 | -573 | N/A | 0 |
| Purchase Of Investment | -54 | -54 | -54 | N/A |
| Investing Cash Flow | $-1,627 | $-628 | $-54 | $0 |
| Cash Flows From Financing Activities | ||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $0 |
| End Cash Position | 92 | 66 | N/A | 0 |
| Net Cash Flow | $92 | $66 | $N/A | $0 |
| Free Cash Flow | ||||
| Operating Cash Flow | 1,719 | 693 | 54 | 0 |
| Capital Expenditure | -1,601 | -573 | N/A | N/A |
| Free Cash Flow | 119 | 120 | 54 | 0 |